Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret Hellard

Showing results (1-10 of 389) with videos related to

Pageof 39
Sort By:
Sexual Health|December 13, 2005
Rising HIV infections in Victoria, the need for a new approach to preventative interventionsRebecca Guy, Margaret Hellard
Addiction (Abingdon, England)|May 13, 2015
The changing landscape of hepatitis C treatment-not 'can we cure?' but 'who should we cure first?' Is this an ethical approach?Margaret Hellard, Nick Scott
Hepatology (Baltimore, Md.)|March 9, 2022
Making child's play of tolerance: Defining the immune-viral interplay during combination entecavir and pegylated interferon therapy for immune-tolerant hepatitis B infectionJessica Howell, Margaret Hellard
Nature|March 31, 2022
Simplify access to hepatitis B careMargaret Hellard, Jessica Howell
Journal of Hepatology|November 26, 2016
Targeted direct-acting antiviral treatment for chronic hepatitis C: A financial reality or an obstacle to elimination?Margaret Hellard, Alisa Pedrana, Nick Scott
Australian and New Zealand Journal of Public Health|August 8, 2007
The feasibility of recruiting young men in rural areas from community football clubs for STI screeningJudy Gold, Jane Hocking, Margaret Hellard
The Australian & New Zealand Journal of Obstetrics & Gynaecology|January 13, 2004
Hepatitis C and pregnancy: an updateMichelle Giles, Margaret Hellard, Joe Sasadeusz
The Lancet. Gastroenterology & Hepatology|April 18, 2021
Affordable treatment and political commitment are crucial to eliminate hepatitis C globallyMargaret Hellard, Alisa Pedrana, Bridget Draper
BMC Infectious Diseases|November 17, 2017
Methodological challenges in appraising evidence on diagnostic testing for WHO guidelines on hepatitis B and hepatitis C virus infectionRoger Chou, Philippa Easterbrook, Margaret Hellard
Journal of Clinical Epidemiology|July 16, 2008
Registered post achieved a higher response rate than normal mail--a randomized controlled trialAlisa Pedrana, Margaret Hellard, Michelle Giles
Pageof 39

Showing results (1-10 of 389) with videos related to

Sort By:
Pageof 39
Sexual Health|December 13, 2005
Rising HIV infections in Victoria, the need for a new approach to preventative interventionsRebecca Guy, Margaret Hellard
Addiction (Abingdon, England)|May 13, 2015
The changing landscape of hepatitis C treatment-not 'can we cure?' but 'who should we cure first?' Is this an ethical approach?Margaret Hellard, Nick Scott
Hepatology (Baltimore, Md.)|March 9, 2022
Making child's play of tolerance: Defining the immune-viral interplay during combination entecavir and pegylated interferon therapy for immune-tolerant hepatitis B infectionJessica Howell, Margaret Hellard
Nature|March 31, 2022
Simplify access to hepatitis B careMargaret Hellard, Jessica Howell
Journal of Hepatology|November 26, 2016
Targeted direct-acting antiviral treatment for chronic hepatitis C: A financial reality or an obstacle to elimination?Margaret Hellard, Alisa Pedrana, Nick Scott
Australian and New Zealand Journal of Public Health|August 8, 2007
The feasibility of recruiting young men in rural areas from community football clubs for STI screeningJudy Gold, Jane Hocking, Margaret Hellard
The Australian & New Zealand Journal of Obstetrics & Gynaecology|January 13, 2004
Hepatitis C and pregnancy: an updateMichelle Giles, Margaret Hellard, Joe Sasadeusz
The Lancet. Gastroenterology & Hepatology|April 18, 2021
Affordable treatment and political commitment are crucial to eliminate hepatitis C globallyMargaret Hellard, Alisa Pedrana, Bridget Draper
BMC Infectious Diseases|November 17, 2017
Methodological challenges in appraising evidence on diagnostic testing for WHO guidelines on hepatitis B and hepatitis C virus infectionRoger Chou, Philippa Easterbrook, Margaret Hellard
Journal of Clinical Epidemiology|July 16, 2008
Registered post achieved a higher response rate than normal mail--a randomized controlled trialAlisa Pedrana, Margaret Hellard, Michelle Giles
Pageof 39